Investment analysts at JPMorgan have recently shifted their stance on the biopharmaceutical sector, highlighting Apellis Pharmaceuticals as a primary beneficiary of current
The landscape of residential real estate is undergoing a significant transformation as the post-pandemic migration patterns begin to stabilize. At the center